These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33053801)

  • 1. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.
    Olson A; Basukala B; Lee S; Gagne M; Wong WW; Henderson AJ
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33053801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.
    Zhang Y; Yin C; Zhang T; Li F; Yang W; Kaminski R; Fagan PR; Putatunda R; Young WB; Khalili K; Hu W
    Sci Rep; 2015 Nov; 5():16277. PubMed ID: 26538064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
    Saayman SM; Lazar DC; Scott TA; Hart JR; Takahashi M; Burnett JC; Planelles V; Morris KV; Weinberg MS
    Mol Ther; 2016 Mar; 24(3):488-98. PubMed ID: 26581162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus.
    Klinnert S; Chemnitzer A; Rusert P; Metzner KJ
    J Gen Virol; 2022 Jun; 103(6):. PubMed ID: 35671066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-mediated Activation of Latent HIV-1 Expression.
    Limsirichai P; Gaj T; Schaffer DV
    Mol Ther; 2016 Mar; 24(3):499-507. PubMed ID: 26607397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.
    Dampier W; Sullivan NT; Mell JC; Pirrone V; Ehrlich GD; Chung CH; Allen AG; DeSimone M; Zhong W; Kercher K; Passic S; Williams JW; Szep Z; Khalili K; Jacobson JM; Nonnemacher MR; Wigdahl B
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):950-960. PubMed ID: 29968495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
    Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
    J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.
    Darcis G; Das AT; Berkhout B
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29596334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models.
    da Costa LC; Bomfim LM; Dittz UVT; Velozo CA; da Cunha RD; Tanuri A
    Retrovirology; 2022 Jun; 19(1):12. PubMed ID: 35733180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery.
    Klinnert S; Schenkel CD; Freitag PC; Günthard HF; Plückthun A; Metzner KJ
    Gene Ther; 2024 Mar; 31(3-4):74-84. PubMed ID: 37558852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.
    Bialek JK; Dunay GA; Voges M; Schäfer C; Spohn M; Stucka R; Hauber J; Lange UC
    PLoS One; 2016; 11(6):e0158294. PubMed ID: 27341108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
    Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
    Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
    Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
    Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
    Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
    Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
    Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
    Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas based antiviral strategies against HIV-1.
    Wang G; Zhao N; Berkhout B; Das AT
    Virus Res; 2018 Jan; 244():321-332. PubMed ID: 28760348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Mefferd AL; Bogerd HP; Irwan ID; Cullen BR
    Virology; 2018 Jul; 520():116-126. PubMed ID: 29857168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing integrated SIV proviral DNA with TAR-specific CRISPR tools.
    Smith LM; Hodara VL; Parodi LM; Callery JE; Giavedoni LD
    J Med Primatol; 2020 Oct; 49(5):269-279. PubMed ID: 32905624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.
    Huang Z; Nair M
    Sci Rep; 2017 Jul; 7(1):5955. PubMed ID: 28729655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.